NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders
Abstract Chromatin modifiers, owing to their enzymatic activities and frequent overexpression or hyperactivation in cancer, have emerged as promising therapeutic targets. Among these, the nuclear receptor-binding SET domain (NSD) family of proteins catalyzes lysine methylation—a key histone post-tra...
| 出版年: | Cellular and Molecular Life Sciences |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Springer
2025-06-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/s00018-025-05806-6 |